regard
sampl
data
share
recogn
import
global
influenza
surveil
respons
system
gisr
pandem
influenza
prepared
pip
framework
well
global
initi
share
influenza
data
gisaid
berlin
declar
health
minist
may
global
influenza
surveil
respons
system
gisr
formerli
known
global
influenza
surveil
network
evolv
integr
scientif
technic
global
collabor
fulfil
object
activ
global
influenza
programm
gip
initi
one
initi
programm
newli
establish
world
health
organis
seventi
year
relev
today
estim
one
billion
case
influenza
annual
million
sever
caus
even
given
constant
pandem
threat
recent
novel
zoonot
influenza
infect
princip
object
remain
littl
chang
modu
operandi
adapt
chang
intellectu
technic
polit
environ
follow
introduct
first
influenza
vaccin
appreci
need
vaccin
compon
reflect
chang
circul
virus
establish
global
influenza
surveil
network
recognis
need
monitor
chang
virus
relat
impact
diseas
thu
outset
global
network
encompass
surveil
epidemiolog
impact
influenza
share
virus
isol
design
nation
influenza
centr
nic
collabor
centr
influenza
cc
antigen
characteris
virus
select
suitabl
vaccin
virus
relat
manufactur
regul
administrationdistribut
influenza
vaccin
initi
time
rel
littl
detail
knowledg
virus
structur
mechan
infect
ecolog
among
influenza
virus
infect
human
anim
research
high
prioriti
method
viru
detect
analysi
antigen
properti
also
fundament
virolog
properti
viru
mani
advanc
understand
influenza
made
close
associ
free
share
virus
inform
provid
vital
resourc
research
commun
thu
revel
protein
composit
segment
natur
viru
genom
structur
sequenc
relationship
segment
relat
genet
reassort
antigen
relationship
anim
human
influenza
basi
close
associ
work
member
network
cc
particular
elucid
crystal
structur
haemagglutinin
ha
provid
first
clear
understand
molecular
level
antigen
differ
receptor
specif
human
anim
virus
relat
host
rang
mechan
viru
entri
cell
gener
mechan
membran
notabl
research
resist
immun
infect
discoveri
uncov
peptid
basi
scientif
excel
within
gisr
provid
intellectu
author
credibl
confid
verac
biannual
recommend
vaccin
composit
also
proceduresmethod
guidanc
interpret
tool
develop
anticip
risk
season
antigenicgenet
variant
emerg
zoonot
infect
monitor
antivir
resist
also
close
align
fundament
interest
mechan
antivir
action
emerg
resist
thu
studi
resist
amantadin
reveal
target
novel
proton
emerg
resist
virus
amantadin
virus
oseltamivir
illustr
use
antivir
elimin
due
adaptationevolut
virus
emphasis
import
continu
monitor
antivir
suscept
conduct
mani
nic
cc
develop
altern
agent
combin
therapi
driven
need
know
best
combat
influenza
improv
efficaci
vaccin
effect
vaccin
use
antivir
reduc
diseas
gisr
kept
abreast
scientif
technic
molecular
diagnosi
larg
replac
biolog
method
viru
detect
laboratori
sequenc
ng
impact
balanc
antigen
genet
characteris
virus
outbreak
bird
flu
hong
kong
high
rate
caught
gener
public
imagin
emphasis
import
pandem
prepared
viru
spread
togeth
outbreak
sar
coronaviru
zoonot
influenza
chang
dynam
brought
much
greater
promin
influenza
exposur
gisr
structur
rel
respons
understood
well
differ
compon
larg
inform
autonom
system
compris
cc
nic
erl
essenti
regulatori
laboratori
coordin
gip
persist
threat
call
wider
appreci
oper
benefit
especi
regard
abil
respond
event
pandem
first
time
govern
face
concept
prepar
vaccin
stockpil
vaccin
antivir
use
event
viru
becam
transmiss
caus
epidem
possibl
pandem
garner
concert
effort
among
public
health
offici
regul
vaccin
manufactur
well
among
academ
scientist
toward
develop
better
vaccin
antivir
therapi
also
led
much
greater
govern
scrutini
fair
global
system
particular
countri
use
season
influenza
vaccin
benefit
tangibl
particip
contribut
gisr
share
virus
ensu
intergovernment
negoti
culmin
pandem
influenza
prepared
framework
pip
fw
formal
agreement
member
state
ms
promot
improv
pandem
prepared
respons
wherebi
share
virus
influenza
virus
human
pandem
potenti
ivpp
would
match
access
countri
particular
develop
countri
vaccin
antivir
benefit
event
pandem
key
element
introduct
influenza
viru
track
mechan
ivtm
monitor
share
ivpp
requir
sign
materi
transfer
agreement
defin
pip
receiv
pip
biolog
materi
gisr
alter
way
virus
openli
share
within
beyond
gisr
addit
contribut
vaccin
diagnost
antivir
made
avail
deploy
pandem
contribut
also
academ
laboratori
pharmaceut
compani
make
financi
partnership
contribut
pc
use
support
countri
particip
gisr
help
bolster
capac
develop
countri
build
pandem
prepared
respons
capabl
thu
strengthen
gisr
advantag
term
support
gisr
pandem
prepared
implement
pip
fw
overseen
pip
advisori
group
administr
legal
support
pip
secretariat
introduc
import
new
element
specif
respect
monitor
share
pip
biolog
materi
longstand
success
organis
oper
gisr
coordin
gip
therefor
import
emphasis
recent
review
pip
ensur
implement
close
align
integr
activ
oper
respons
gip
gisr
envisag
pip
reorganis
within
chang
consequ
implement
nagoya
protocol
convent
biolog
like
impact
gisr
respect
nation
well
intern
respons
gisr
compon
maintain
fundament
structur
essenti
autonomi
gisr
diminish
contribut
gisr
global
public
health
gisr
provid
excel
exampl
effect
earli
warn
system
time
report
share
urgent
inform
well
effici
effect
model
cooper
industri
reflect
uniqu
featur
influenza
combin
annual
epidem
zoonot
threat
sever
pandem
rais
question
best
leverag
advantag
gener
benefit
respons
emerg
viru
diseas
demonstr
respons
outbreak
tune
season
influenza
surveil
leverag
gisr
pilot
programm
develop
evid
base
inform
futur
vaccin
polici
nation
global
level
recent
expans
number
capac
nic
past
decad
countri
particip
global
influenza
surveil
due
part
pandem
threat
zoonot
infect
etc
requir
notif
intern
health
regul
ihr
human
infect
novel
influenza
virus
well
respons
pandem
bolster
activ
technic
support
provis
protocol
cdc
diagnost
reagent
detect
season
zoonot
novel
infect
regularli
updat
includ
train
associ
perform
evalu
momentum
like
continu
provis
guidanc
document
analysi
tool
gip
continu
enhanc
capabl
laboratori
conduct
epidemiolog
virolog
surveil
evalu
burden
diseas
influenza
influenza
might
impact
diseas
essenti
develop
season
vaccin
increas
countri
flu
vaccin
polici
complement
increas
global
vaccin
distribut
bode
well
futur
hand
sustain
guarante
especi
none
perceiv
pandem
threat
materialis
resourc
judg
better
employ
elsewher
mainten
basic
season
surveil
capac
laboratori
network
member
state
nic
independ
financi
support
partnership
contribut
pip
fw
extern
fund
essenti
critic
sustain
nation
capabl
respond
season
epidem
futur
pandem
surveil
influenza
part
integr
diseas
surveil
like
becom
preval
multipl
parallel
analysi
system
becom
sensit
test
improv
time
respons
gisr
pandem
commend
review
committe
function
ihr
relat
pandem
acknowledg
first
time
worldwid
laboratori
initi
extend
period
time
caution
world
respond
sever
influenza
pandem
activ
particip
monitor
understand
impact
season
epidem
togeth
season
vaccin
use
envisag
global
agenda
influenza
surveil
control
subsequ
global
action
plan
influenza
gap
crucial
import
countri
prepar
react
effect
enact
plan
assist
exampl
distribut
vaccin
antivir
pandem
possibl
stockpil
mobilis
pip
fw
focu
increas
emphasi
influenza
pandem
potenti
zoonot
infect
pandem
influenza
surveil
season
influenza
nic
provid
bedrock
global
system
surveil
abil
respond
pandem
strong
scientif
base
expertis
mani
nic
reflect
larg
extent
nation
public
health
respons
part
local
healthcar
system
go
beyond
influenza
includ
gener
emerg
respons
capabl
nic
core
function
reflect
interdepend
diagnosi
virolog
surveil
novel
viru
characteris
epidemiolog
outbreak
prepared
investig
well
appli
research
improv
test
methodolog
medic
countermeasur
increas
role
genet
autom
health
care
system
reflect
move
away
isol
influenza
virus
increas
relianc
nic
gene
sequenc
viru
characteris
enabl
track
viru
detect
monitor
antivir
resist
increas
wider
applic
sequenc
technolog
sequenc
enhanc
understand
molecular
genet
viru
infect
epidemiolog
enabl
respons
outbreak
diseas
essenti
aspect
network
coordin
respons
gip
effect
rapid
collat
share
inform
via
flunet
virolog
data
fluid
epidemiolog
data
includ
viru
genet
sequenc
data
associ
inform
well
share
virus
refer
reagent
gisr
also
provid
backdrop
success
establish
global
initi
share
influenza
data
gisaid
becom
integr
compon
collect
analysi
time
share
essenti
influenza
viru
data
develop
time
intergovernment
deliber
share
virus
extens
discuss
involv
broad
rang
interest
includ
govern
public
health
offici
scientist
intellectu
properti
expert
well
gisr
best
promot
time
share
genet
sequenc
data
gsd
result
gisaid
data
share
mechan
essenc
databas
access
agreement
daa
govern
share
data
databas
daa
enshrin
code
conduct
provid
user
data
protect
ownership
data
make
freeli
avail
proviso
user
acknowledg
sourc
data
appropri
engag
origin
data
collabor
spirit
gisr
manner
consist
origin
effect
demonstr
prompt
releas
genet
sequenc
first
case
zoonot
infect
china
enabl
rapid
product
synthet
biolog
candid
vaccin
viru
within
ensur
avail
latest
data
biannual
vaccin
consult
meet
vcm
close
align
principl
underli
gisaid
share
mechan
seven
key
principl
data
share
public
health
emerg
enunci
recent
global
research
collabor
infecti
diseas
prepared
illustr
gisr
lead
way
implement
innov
mechan
procedur
gisaid
also
system
integr
gsd
clinic
virolog
epidemiolog
data
take
advantag
latest
advanc
rapid
gene
sequenc
technolog
serv
good
exampl
share
gsd
relat
public
health
emerg
perhap
serv
exampl
pathogen
ebola
zika
crucial
aspect
gisr
part
success
meet
strict
timelin
vaccin
viru
select
manufactur
qualiti
control
vaccin
prior
distribut
process
take
thu
develop
assist
interpret
data
anticip
potenti
futur
antigen
chang
like
benefici
avoid
mismatch
vaccin
circul
strain
reduc
vaccin
effect
occur
northern
hemispher
vaccin
due
late
emerg
antigen
variant
around
time
vcm
februari
problem
serv
illustr
inher
limit
virolog
surveil
link
inflex
timelin
vaccin
product
antigen
chang
often
explain
term
amino
acid
chang
identifi
genet
signatur
predict
chang
antigen
locat
amino
acid
chang
structur
ha
still
anticip
futur
fit
trajectori
particular
genet
variant
use
predict
assess
use
support
candid
vaccin
viru
select
especi
increas
volum
sequenc
data
afford
better
trajectori
help
prioritis
like
emerg
variant
group
detail
antigen
characteris
product
candid
vaccin
virus
cvv
may
possibl
anticip
emerg
futur
antigen
yet
evid
whether
adopt
futurist
vaccin
strain
would
would
advantag
vaccin
effect
asid
iron
technic
advanc
molecular
characteris
antigen
characteris
virus
becom
difficult
due
chang
specif
affin
receptor
bind
consequ
agglutin
red
blood
cell
differ
speci
addit
chang
conclus
result
antigen
relationship
longer
guarante
simpl
haemagglutin
inhibit
hi
test
antigen
characteris
reli
complementari
result
neutralis
attempt
develop
altern
assay
circumv
idiosyncrasi
red
blood
cell
measur
antibodi
inhibit
viru
bind
yet
gener
success
wider
benefit
flow
access
latest
data
evid
advanc
tool
platform
avail
analys
interpret
sequenc
data
exampl
track
influenza
viru
evolut
nextflu
provid
open
access
regularli
updat
analys
latest
genet
antigen
flusurv
tool
integr
databas
assist
interpret
potenti
impact
particular
mutat
antigen
function
antivir
suscept
properti
ha
na
protein
relat
publish
inform
enabl
track
mutat
time
respect
geograph
vaccin
manufactur
long
support
product
high
growth
reassort
cvv
increas
difficulti
obtain
egg
isol
led
closer
collabor
manufactur
cc
erl
reassort
laboratori
increas
number
potenti
cvv
well
investig
use
cell
cvv
first
use
vaccin
usa
part
overcom
potenti
impact
mutat
promot
develop
cell
vaccin
much
learn
mechan
ha
bind
differ
receptor
aviananim
human
cell
variou
avian
subtyp
virus
isol
infect
human
indic
affin
type
receptor
may
repres
intermedi
acquisit
howev
chang
would
requir
environ
would
conduc
chang
ha
viru
protein
effect
effici
transmiss
simpli
thu
tool
influenza
pandem
risk
assess
irat
tipra
provid
compar
assess
perceiv
pandem
threat
zoonot
infect
term
sever
base
eg
ratio
likelihood
base
frequenc
human
infect
characterist
viru
assess
limit
predict
capac
virus
capac
transmit
respiratori
droplet
increas
transmiss
infect
peopl
yet
detect
even
largest
outbreak
emerg
highli
pathogen
avian
influenza
nevertheless
structur
framework
upon
base
assess
zoonot
virus
imperfect
provid
mechan
prioritis
risk
associ
specif
virus
doubt
enhanc
collabor
anim
health
human
health
sector
one
health
banner
also
help
optimis
avail
use
inform
clear
lack
fundament
knowledg
predict
likelihood
particular
subtyp
could
caus
pandem
anoth
differ
viru
caus
latest
novel
subtyp
differ
alreadi
circul
emphasis
adventiti
natur
emerg
pandem
viru
number
differ
subtyp
virus
transfer
pig
point
predilect
avian
virus
mammalian
transmiss
moreov
recent
sporad
human
infect
swine
variant
beg
question
extent
pandem
virus
nevertheless
persist
circul
subtyp
almost
year
attest
resili
abil
continu
adapt
human
popul
pandem
threat
also
stimul
gip
becom
proactiv
build
upon
scientif
etho
gisr
har
expertis
wider
influenza
research
commun
develop
public
health
research
agenda
influenza
focu
effort
reduc
risk
zoonot
infect
minimis
impact
well
improv
clinic
manag
updat
identifi
prioriti
next
year
includ
better
understand
burden
season
epidem
influenza
econom
consequ
differ
countri
investig
factor
associ
pathogenesi
clinic
sever
includ
secondari
bacteri
infect
better
understand
host
genet
suscept
improv
healthcar
major
season
influenza
outbreak
well
pandem
effect
use
one
hand
gisr
undergon
revolut
introduct
molecular
genet
techniqu
recent
year
continu
transform
capabl
increas
introduct
ng
multiplex
molecular
platform
high
throughput
care
format
rapid
highli
sensit
specif
diagnosi
respiratori
tract
pathogen
hand
inactiv
vaccin
use
essenc
chang
littl
decad
sinc
introduct
year
ago
applic
synthet
biolog
potenti
tailor
improv
yield
high
growthyield
reassort
remov
exampl
undesir
chang
season
vaccin
seed
virus
given
substanti
lead
time
lack
avail
vaccin
ahead
first
wave
pandem
major
effort
develop
new
univers
vaccin
vaccin
strategi
stimul
broadli
reactiv
antibodi
conserv
epitop
surfac
protein
exampl
ha
immun
intern
confer
protect
broader
rang
influenza
subtyp
least
differ
antigen
variant
within
subtyp
introduct
new
vaccin
impact
work
cc
erl
requir
least
correl
immun
altern
vaccin
potenc
method
moreov
licensur
new
antivir
exampl
target
viru
polymeras
therapeut
monoclon
antibodi
target
exampl
ha
requir
applic
new
phenotyp
assay
complement
molecular
marker
resist
seen
substanti
enhanc
past
decad
gisr
current
compris
institut
includ
nic
countri
member
state
leav
still
room
expans
improv
capac
world
combat
epidem
pandem
influenza
past
experi
gip
look
forward
optim
next
decad
plan
address
challeng
pose
influenza
emerg
respiratori
virus
gip
continu
strengthen
gisr
exampl
better
integr
laboratori
epidemiolog
data
enhanc
intersector
institut
collabor
includ
partnership
maximis
analys
use
avail
data
risk
manag
inform
nation
global
health
polici
threat
highli
pathogen
avian
influenza
viru
caus
zoonot
infect
develop
pandem
akin
caught
imagin
galvanis
global
respons
one
outcom
pip
framework
institut
bolster
fair
transpar
benefit
global
system
import
howev
recognis
awar
potenti
futur
impact
chang
network
larg
autonom
member
state
year
includ
formal
arrang
receiv
addit
financi
support
pip
partnership
contribut
amount
half
estim
run
cost
gisr
involv
behalf
member
state
directli
formal
share
ivpp
given
success
global
influenza
programm
crucial
respons
ensur
addit
resourc
use
best
advantag
synergist
manner
strengthen
gisr
umbrella
gip
enabl
countri
meet
ihr
respons
promot
benefit
share
initi
well
ensur
gisr
extens
complementari
scientif
expertis
collabor
etho
remain
fulli
engag
benefit
global
health
secur
gisr
heart
respons
influenza
improv
vaccin
includ
quest
univers
flu
vaccin
antivir
essenti
improv
world
capabl
overal
effect
control
diseas
gisr
broad
vision
watch
eye
gip
continu
provid
leadership
interact
global
partner
implement
technolog
advanc
better
understand
factor
influenc
adapt
potenti
interspeci
transmiss
virus
host
respons
human
infect
essenti
retain
fundament
characterist
collabor
etho
gisr
evolv
global
influenza
programm
defenc
influenza
form
exampl
integr
global
system
combat
infecti
diseas
